AeroGrow International, Inc. (OTCMKTS:AERO) had worked with numerous top class retailers in this year so as to solve the existing challenges, and the results were remarkable. It closed a chain wide release at Bed Bath & Beyond in more than a thousand outlets.
Now, if a customer went into a BBB outlet in the last quarter of 2016, he must have saw the AeroGarden display on the primary drive aisle. This change in placement, along with in-store merchandising, and a distinct product featured at BBB was successful, as the company achieved over 96% sell in its stores and even realized strong results on BBB.com.
AeroGrow successfully delivered same results at retailer Sur La Table with highlighted retailing sets at all their stores across the holiday season. The performance over the specific outlet was excellent as the company achieved 100% sell through. This strong performance was also recorded on surlatable.com online platform. The team closed assessments at different retailers over the last few weeks and the response received was amazing.
In the segment of kitchen electrics, AeroGarden was believed to the number one selling product category in last holiday season at the popular retailer Bed Bath. This is an amazing achievement as the retailer features established brands in its outlet, and so beating them and coming as a winner is something really astounding.
AeroGrow is putting all efforts with the buying teams of the famous retailers to continue 2016 success through this year and advance considerably bigger programs in 2017 and beyond.
While the company has been associated with BBB and Sur La Table stores since past fall, it also gave a try at selected stores of Ace Hardware and Lowes.
In the last trading session, the stock price of AeroGrow declined more than 3% to close the day at $2.39.
Wall Street PR - BIG BUYOUT OPPORTUNITYhttp://wallstreetpr.com
Here’s how to leverage this breakthrough technology…
Can CBD Oil Get Rid of Chronic Pain?http://www.greenleaf.farm
Pure Colorado Golden CBD Oil Hemp Extracts
2017 Most Disruptive Biotech VBIOhttp://www.financialstrend.com
Disruptive biotech VBIO decodes targeted drug delivery for stem cells